In contrast, 26 (IC50 = 13 nM), also with an imidazopyridine backbone, was found to be a potent, low toxicity inhibitor of TBK1 with promising therapeutic effects in mice against autoimmune diseases such as systemic lupus erythematosus (Figure 14) (172). The gene discussed is TBK1; the disease is autoimmune disease.